Regulatory T cells in human disease and their potential for therapeutic manipulation

Immunology

Volumn 118, Issue 1, 2006, Pages 1-9

  Taams, Leonie S ^a,f   Palmer, Donald B ^b   Akbar, Arne N ^c   Robinson, Douglas S ^d   Brown, Zarin ^e   Hawrylowicz, Catherine M ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Allergy; Autoimmunity; Immune regulation; T lymphocytes; Tolerance

Indexed keywords

BACTERIAL HEAT SHOCK PROTEIN DNAJP1; BACTERIAL PROTEIN; BASILIXIMAB; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCITRIOL; CD3 ANTIBODY; CD45 RO RB ANTIBODY; COLECALCIFEROL; CTLA4 ANTIBODY; GLUCOCORTICOID; GLUTAMATE DECARBOXYLASE; HUMAN OKT3G1; IMMUNOSUPPRESSIVE AGENT; INFLUENZA PEPTIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD28; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEPTIDE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ALLERGY; ANTIGEN SPECIFICITY; ASTHMA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL INFECTION; CANCER; CANCER RISK; CELL FUNCTION; CELLULAR IMMUNITY; DESENSITIZATION; DIABETES MELLITUS; HELICOBACTER INFECTION; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOTHERAPY; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION;

AUTOIMMUNITY; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNE TOLERANCE; IMMUNOTHERAPY; INFECTION; NEOPLASMS; T-LYMPHOCYTES, REGULATORY;

EID: 33645819388     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2006.02348.x     Document Type: Review

References (89)

1. Shevach EM. CD4+CD25+ suppressor T cells: more questions than answers. Nat Rev Immunolq16 2002 2 389 400.
2. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nature Immunol 2005 6 345 52.
3. Maloy KJ Powrie F. Regulatory T cells in the control of immune pathology. Nature Immunol 2001 2 816 22.
4. Roncarolo M-G Bacchetta R Bordignon C Narula S Levings MK. Type 1 T regulatory cells. Immunol Rev 2001 182 68 79.
5. Hawrylowicz CM O'Garra A. Potential role of interleukin-10 secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 2005 5 271 83.
6. Weiner HL. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory T cells. Immunol Rev 2001 182 207 14.
7. Gorelik L Flavell RA. Transforming growth factor-β in T cell biology. Nat Rev Immunol 2002 2 46 53.
8. Ramsdell F. Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity 2003 19 165 8.
9. Bennett CL Christie J Ramsdell F et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001 27 20 1.
10. Wildin R Ramsdell F Peake J et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001 27 18 20.
11. Walker MR Kasprowicz DJ Gersuk VH Benard A Van Landeghen M Buckner JH Ziegler SF. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25-q17 T cells. J Clin Invest 2003 112 1437 43.
12. Morgan ME van Bilsen JHM Bakker AM et al. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol 2005 66 13 20.
13. Viglietta V Baecher-Allan C Weiner HL Hafler DA. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004 199 971 9.
14. Kriegel MA Lohmann T Gabler C Blank N Kalden JR Lorenz HM. Defective suppressor function of human CD4+ CD25+ regulatory T cells in Autoimmune Polyglandular Syndrome Type II. J Exp Med 2004 199 1285 91.
15. Lindley S Dayan CM Bishop A Roep BO Peakman M Tree TIM. Defective suppressor function in CD4+CD25+ T-cells from patients with type 1 diabetes. Diabetes 2005 54 92 9.
16. Sugiyama H Gyulai R Toichi E Garaczi E Shimada S Stevens SR McCormick TS Cooper KD. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: Mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 2005 174 164 73.
17. Balandina A Lecart S Dartevelle P Saoudi A Berrih-Aknin S. Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 2005 105 735 41.
18. Ehrenstein MR Evans JG Singh A Moore S Warnes G Isenberg DA Mauri C. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF-α therapy. J Exp Med 2004 200 277 85.
19. van Amelsfort JMR Jacobs KMG Bijlsma JWJ Lafeber FPJG Taams LS. CD4+CD25+ regulatory T cells in rheumatoid arthritis: differences in presence, phenotype and function between peripheral blood and synovial fluid. Arthritis Rheum 2004 50 2775 85.
20. de Kleer IM Wedderburn LR Taams LS et al. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of Juvenile Idiopathic Arthritis. J Immunol 2004 172 6435 43.
21. Cao D Vollenhoven RV Klareskog L Trollmo C Malmstrom V. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 2004 6 R335 46.
22. Mottonen M Heikkinen J Mustonen L Isomaki P Luukkainen R Lassila O. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 2005 140 360 7.
23. Ruprecht CR Gattorno M Ferlito F Gregorio A Martini A Lanzavecchia A Sallusto F. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med 2005 201 1793 803.
24. Ling EM Smith T Nguyen XD Pridgeon C Dallman M Arbery J Carr VA Robinson DS. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004 363 608 15.
25. Grindebacke H Wing K Andersson A-C Suri-Payer E Rak S Rudin A. Defective suppression of Th2 cytokines by CD4+CD25+ regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 2004 34 1364 72.
26. Bellinghausen I Klostermann B Knop J Saloga J. Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J Allergy Clin Immunol 2003 111 862 8.
27. Taams LS Vukmanovic-Stejic M Smith J et al. Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol 2002 32 1621 30.
28. Cavani A Nasorri F Ottaviani C Sebastiani S De Pita O Girolomoni G. Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J Immunol 2003 171 5760 8.
29. Akdis M Verhagen J Taylor A et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004 199 1567 75.
30. Tiemessen MM Van Ieperen-Van Dijk AG Bruijnzeel-Koomen CAFM Garssen J Knol EF Van Hoffen E. Cow's milk-specific T-cell reactivity of children with and without persistent cow's milk allergy: Key role for IL-10. J Allergy Clin Immunol 2004 113 932 9.
31. Hawrylowicz C Richards D Loke TK Corrigan C Lee T. A defect in corticosteroid-induced IL-10 production in T lymphocytes from corticosteroid-resistant asthmatic patients. J Allergy Clin Immunol 2002 109 369 70.
32. Akdis CA Blesken T Akdis M Wüthrich B Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998 102 98 106.
33. Karlsson MR Rugtveit J Brandtzaeg P. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 2004 199 1679 88.
34. Robinson DS Larche M Durham SR. Tregs and allergic disease. J Clin Invest 2004 114 1389 97.
35. O'Garra A Vieira PL Vieira P Goldfeld AE. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest 2004 114 1372 8.
36. Mills KHG. Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 2004 4 841 55.
37. Belkaid Y Rouse BT. Natural regulatory T cells in infectious disease. Nature Immunol 2005 6 353 60.
38. Lundgren A Suri-Payer E Enarsson K Svennerholm A-M Lundin BS. Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun 2003 71 1755 62.
39. Lundgren A Stromberg E Sjoling A et al. Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients. Infect Immun 2005 73 523 31.
40. Yazdanbakhsh M Kremsner PG van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002 296 490 4.
41. Satoguina J Mempel M Larbi J et al. Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). Microbes Infection 2002 4 1291 300.
42. Cabrera R Tu Z Xu Y Firpi RJ Rosen HR Liu C Nelson DR. An immunomodulatory role for CD4(+) CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004 40 1062 71.
43. Stoop JN van der Molen RG Baan CC van der Laan LJ Kuipers EJ Kusters JG Janssen HL. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005 41 771 8.
44. Sugimoto K Ikeda F Stadanlick J Nunes FA Alter HJ Chang KM. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 2003 38 1437 48.
45. Aandahl EM Michaelsson J Moretto WJ Hecht FM Nixon DF. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 2004 78 2454 9.
46. Weiss L Donkova-Petrini V Caccavelli L Balbo M Carbonneil C Levy Y. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004 104 3249 56.
47. Eggena MP Barugahare B Jones N Okello M Mutalya S Kityo C Mugyenyi P Cao H. Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 2005 174 4407 14.
48. Kinter AL Hennessey M Bell A et al. CD25+CD4+ Regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4+ and CD8+ HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 2004 200 331 43.
49. Woo EY Yeh H Chu CS Schlienger K Carroll RG Riley JL Kaiser LR June CH. Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol 2002 168 4272 6.
50. Wolf AM Wolf D Steurer M Gastl G Gunsilius E Grubeck-Loebenstein B. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003 9 606 12.
51. Liyanage UK Moore TT Joo H-G et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002 169 2756 61.
52. Viguier M Lemaitre F Verola O et al. Foxp3 expressing CD4+CD25high regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 2004 173 1444 53.
53. Ormandy LA Hillemann T Wedemeyer H Manns MP Greten TF Korangy F. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 2005 65 2457 64.
54. Curiel T Coukos G Zou L et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Med 2004 10 942 9.
55. Marshall NA Christie LE Munro LR Culligan DJ Johnston PW Barker RN Vickers MA. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 2004 103 1755 62.
56. Fiore F Nuschak B Peola S et al. Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells. Eur J Immunol 2005 35 1155 63.
57. Wood KJ Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003 3 199 210.
58. Waldmann H Graca L Cobbold S Adams E Tone M Tone Y. Regulatory T cells and organ transplantation. Semin Immunol 2004 16 119 26.
59. Bacchetta R Bigler M Touraine J et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 1994 179 493 502.
60. Bellinghausen I Metz G Enk AH Christmann S Knop J Saloga J. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 1997 27 1131 9.
61. Smith TR Alexander C Kay AB Larche M Robinson DS. Cat allergen peptide immunotherapy reduces CD4(+) T cell responses to cat allergen but does not alter suppression by CD4(+) CD25(+) T cells: a double-blind placebo-controlled study. Allergy 2004 59 1097 101.
62. Wan S LeClerc J-L Vincent J-L. Cytokine responses to cardiopulmonary bypass: Lessons learned from cardiac transplantation. Ann Thorac Surg 1997 63 269 76.
63. Richards DF Fernandez M Caulfield J Hawrylowicz CM. Glucocorticoids drive human CD8(+) T cell differentiation towards a phenotype with high IL-10 and reduced IL-4, IL-5 and IL-13 production. Eur J Immunol 2000 30 2344 54.
64. Karagiannidis C Akdis M Holopainen P et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004 114 1425 33.
65. Dao Nguyen X Robinson DS. Fluticasone propionate increases CD4CD25 T regulatory cell suppression of allergen-stimulated CD4CD25 T cells by an IL-10-dependent mechanism. J Allergy Clin Immunol 2004 114 296 301.
66. Barrat FJ Cua DJ Boonstra A et al. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002 195 603 16.
67. Gregori S Casorati M Amuchastegui S Smiroldo S Davalli AM Adorini L. Regulatory T cells induced by 1α,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001 167 1945 53.
68. Peek EJ Richards DF Faith A Lavender P Lee TH Corrigan CJ Hawrylowicz CM. Interleukin-10-secreting 'regulatory' T cells induced by glucocorticoids and β2-agonists. Am J Respir Cell Mol Biol 2005 33 105 11.
69. Xystrakis E Kusumakar S Boswell S et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 2006 116 146 55. Epub ahead of print.q18
70. Hoffmann P Eder R Kunz-Schughart LA Andreesen R Edinger M. Large-scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells. Blood 2004 104 895 903.
71. Godfrey WR Ge YG Spoden DJ Levine BL June CH Blazar BR Porter SB. In vitro expanded human CD4+CD25+ T regulatory cells can markedly inhibit allogeneic dendritic cell stimulated MLR cultures. Blood 2004 104 453 61.
72. Lin C-H Hünig T. Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur J Immunol 2003 33 626 38.
73. Fujio K Okamoto A Tahara H Abe M Jiang Y Kitamura T Hirose S Yamamoto K. Nucleosome-specific regulatory T cells engineered by triple gene transfer suppress a systemic autoimmune disease. J Immunol 2004 173 2118 25.
74. Jiang S Camara N Lombardi G Lechler RI. Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex-vivo. Blood 2003 101 2180 86.
75. Jonuleit H Schmitt E Steinbrink K Enk AH. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 2001 22 394 400.
76. Dhodapkar MV Steinman RM Krasovsky J Munz C Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 2001 193 233 8.
77. Larche M Wraith DC. Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med 2005 11 569 76.
78. Kappos L Comi G Panitch H et al. Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. Nat Med 2000 6 1176 82.
79. Pedotti R Sanna M Tsai M DeVoss J Steinman L McDevitt H Galli S. Severe anaphylactic reactions to glutamic acid decarboxylase (GAD) self peptides in NOD mice that spontaneously develop autoimmune type 1 diabetes mellitus. BMC Immunol 2003 4 2.
80. Prakken BJ Samodal R Le TD et al. Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis. Proc Natl Acad Sci USA 2004 101 4228 33.
81. Verhoef A Alexander C Kay AB Larche M. T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity. PLoS Medicine 2005 2 253 61.
82. Herold KC Gitelman SE Masharani U et al. A single course of anti-CD3 monoclonal antibody hOKT3γ1 (Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 2005 54 1763 9.
83. Keymeulen B Vandemeulebroucke E Ziegler AG et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005 352 2598 608.
84. Belghith M Bluestone JA Barriot S Megret J Bach J-F Chatenoud L. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 2003 9 1202 8.
85. Gregori S Mangia P Bacchetta R et al. An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells. J Exp Med 2005 201 1293 305.
86. Shimizu J Yamazaki S Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999 163 5211 8.
87. Sutmuller RPM van Duivenvoorde LM van Elsas A et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001 194 823 32.
88. Phan GQ Yang JC Sherry RM et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci USA 2003 100 8372 7.
89. Mottet C Uhlig HH Powrie F. Cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003 170 3939 43.